2024-514748-10-00CompletedPhase 1
Study to evaluate food effect on the pharmacokinetics of mesalazine oral formulation in healthy volunteers.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 May 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 22 Jul 2024
- Start date
- 28 Nov 2024
- Lead sponsor
- Faes Farma S.A.
- EU CT number
- 2024-514748-10-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 34
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.